AMGN - AMGEN INC
IEX Last Trade
262.5
-0.450 -0.171%
Share volume: 24,783
Last Updated: Fri 27 Dec 2024 08:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$262.95
-0.45
-0.17%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-05 | 2022-11-04 | 2023-02-09 | 2023-04-28 | 2023-08-04 | 2023-10-31 | 2024-02-14 | 2024-05-03 | |
| Total revenue | 6.594 B | 6.652 B | 6.839 B | 6.105 B | 6.986 B | 6.903 B | 8.196 B | 7.447 B | |
| Cost of revenue | 1.510 B | 1.588 B | 1.747 B | 1.720 B | 1.813 B | 1.806 B | 3.112 B | 3.200 B | |
| Gross profit | 5.084 B | 5.064 B | 5.092 B | 4.385 B | 5.173 B | 5.097 B | 5.084 B | 4.247 B | |
| -0.39% | 0.55% | -13.88% | 17.97% | -1.47% | -0.26% | -16.46% | |||
| Operating expenses | 2.366 B | 2.399 B | 2.896 B | 2.316 B | 2.407 B | 2.432 B | 3.808 B | 3.151 B | |
| Selling general and admin | 1.327 B | 1.287 B | 1.572 B | 1.258 B | 1.294 B | 1.353 B | 2.274 B | 1.808 B | |
| Research and development | 1.039 B | 1.112 B | 1.324 B | 1.058 B | 1.113 B | 1.079 B | 1.534 B | 1.343 B | |
| Total expenses | 3.876 B | 3.987 B | 5.146 B | 4.036 B | 4.220 B | 4.882 B | 7.155 B | 6.456 B | |
| 2.86% | 29.07% | -21.57% | 4.56% | 15.69% | 46.56% | -9.77% | |||
| Operating income | 2.718 B | 2.665 B | 1.693 B | 2.069 B | 2.766 B | 2.021 B | 1.041 B | 991.000 M | |
| Ebit | 2.176 B | 2.660 B | 2.230 B | 1.921 B | 2.684 B | 2.021 B | 1.271 B | 991.000 M | |
| Pretax income | 1.531 B | 2.392 B | 1.748 B | 3.442 B | 1.614 B | 1.947 B | 852.000 M | -68.000 M | |
| 56.24% | -26.92% | 96.91% | -53.11% | 20.63% | -56.24% | -107.98% | |||
| Income tax | 214.000 M | 249.000 M | 132.000 M | 601.000 M | 235.000 M | 217.000 M | 85.000 M | 45.000 M | |
| Net income basic | 1.317 B | 2.143 B | 1.616 B | 2.841 B | 1.379 B | 1.730 B | 767.000 M | -113.000 M | |
| 62.72% | -24.59% | 75.80% | -51.46% | 25.45% | -55.66% | -114.73% | |||
| Net income | 1.317 B | 2.143 B | 1.616 B | 2.841 B | 1.379 B | 1.730 B | 767.000 M | -113.000 M | |
| 62.72% | -24.59% | 75.80% | -51.46% | 25.45% | -55.66% | -114.73% |